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uality metrics are a cornerstone in healthcare reform. The Centers for Medicare and Medicaid Services assess healthcare institutions' performance by measures of adverse events, such as readmission rates, complications, and hospital-acquired conditions. 1 Although such metrics remain important in healthcare delivery, critical patient-centered outcomes, such as improvement in quality of life (QoL), are not routinely collected. In current models, a poorly performed procedure for the treatment of a chronic condition, such as ablation of atrial fibrillation (AF), can still score high on quality and performance metrics in the absence of procedural complications while potentially not providing any benefit to the patient.
Symptom management is a cornerstone in clinical care, yet symptoms and physical impairments frequently go undetected or underreported. 2 This limits quality of care assessments and comparative effectiveness research 3 and translates into missed opportunities for interventions to improve the delivery of excellent clinical care.
The importance of patient-reported outcomes (PRO) is increasingly recognized as a paramount factor in the development of patient-centered care. 4 ,5 PRO may allow assessment of disease progression, treatment efficacy, and health-related QoL which should be cornerstone in assessing quality of care in any patient-centered approach. However, the burden of longitudinal data collection may be cost prohibitive in an era of cost reduction. Both Centers for Medicare and Medicaid Services and the Office of the National Coordinator for Health Information Technology recognize the value of collecting PRO data but have not created strong financial incentives for its implementation. Atrial fibrillation ablation is most commonly performed for symptom relief, yet most outcomes in clinical research report arrhythmia recurrence and proposed registries only record acute outcomes mostly pertaining to complications. Most AF programs rarely have longitudinal arrhythmia follow-up, and to our knowledge, no program has longitudinal QoL or symptoms assessment.
We sought to develop an efficient method to collect longitudinal PRO using an automated system. This new model was implemented in our practice of AF ablation with a national referral base; inherently with challenging longitudinal clinical follow-up data collection.
METHODS
The automated remote follow-up system for PRO data collection was designed and built at the Cleveland Clinic's section of cardiac electrophysiology and pacing at the Heart and Vascular Institute (Cleveland, OH), in collaboration with a team from the Human-Computer Interaction Institute at Carnegie Mellon University (Pittsburgh, PA). The current study was approved by the institutional review board. All patients gave informed consents before the ablation procedures. The data that support the findings of this study are available from the corresponding author on reasonable request.
Automated PRO System Development
The Human-Computer Interaction Institute team researched patients' and physicians' needs in longitudinal PRO collection. The goal was to design an efficient platform that allows patients to easily report and physicians to easily collect patient-centered outcomes. Patient and physician surveys and interviews were conducted to guide PRO system development. After conclusion of the initial stage of surveys and interviews, an iterative prototyping approach was used in automated follow-up system design; with continuous user testing and feedback from patients and physicians. The design implemented concepts form social psychology and game mechanics in an effort to keep patients engaged. A video appeal from the treating physician was incorporated; encouraging patient participation and emphasizing the importance of targeted data. The automated remote follow-up system for PRO data collection was then built under a contract with a private software developer. An internal team of information technologists at the Cleveland Clinic integrated the system with electronic medical records and an internal prospectively maintained data registry of cardiac electrophysiological procedures and outcomes.
WHAT IS KNOWN?
• The value of patient-reported outcomes (PRO) is increasingly recognized in patient-centered care, but longitudinal data collection may be challenging and cost prohibitive.
• Atrial fibrillation (AF) ablation is most commonly performed for symptom relief yet most outcomes in clinical research report arrhythmia recurrence and proposed registries only record acute outcomes mostly pertaining to complications. • For procedures aiming to improve quality of life, such as AF ablation, automating PRO collection, would provide a cost-effective way to maintain longitudinal data and assess clinical improvement.
WHAT THE STUDY ADDS?
• An automated platform for collection of PRO, applied in a prospective cohort of AF ablation, allowed longer duration of follow-up and followup data availability on more patients when combined with routine care versus routine care alone.
• An automated PRO data collection platform allowed collection of a large number of diseasespecific variables related to symptoms, quality of life, and healthcare utilization. • In PRO, there was a significant improvement in quality of life, reduction in AF burden and associated healthcare utilization including emergency visits and hospitalizations, after the AF ablation procedures.
Automated PRO in AF Ablation
For the initial application, the automated PRO system was used to collect healthcare related QoL measures in AF patients undergoing ablation procedures. The atrial fibrillation severity scale, a validated questionnaire for QoL assessment in atrial fibrillation, was used with focus on symptom severity. [6] [7] [8] The AF Symptom Severity Score from the atrial fibrillation severity scale is a composite of 7 symptom-related questions. A score of 0 (no symptoms) to 5 (worse symptoms) is reported for each parameter. The overall score is a sum of the 7 AF-related symptoms. Total scores range between 0 and 35 with higher scores indicating worse symptoms and increasing negative impact on QoL. In addition to the atrial fibrillation severity scale and its components, the surveys assessed for patientreported clinical improvement and QoL, AF burden, including frequency and duration of events, as well as AF associated healthcare utilization, such as emergency room visits, hospitalizations, and medical therapies.
For all AF patients scheduled for an ablation procedure, the system automatically sends email invitations to survey for disease-specific QoL assessment 10 days before scheduled procedure, 3 and 6 months after the procedure, and every 6 months thereafter. Follow-up surveys begin with a video from the treating physician and conclude with a thank you video from the Section Head of Clinical Cardiac Electrophysiology. Patients who did not have email addresses at baseline were encouraged to create email addresses to enhance patient inclusion and participation.
AF Ablation and Routine Clinical Follow-Up
The ablation procedures targeted isolation of the pulmonary veins. Additional nonpulmonary vein ablations were performed at the discretion of the operators. Clinical data are collected before the ablation procedures, on the day of ablation, and subsequent follow-up visits and were continuously updated in our prospectively maintained AF registry and electronic medical records. All clinical documentation, including telephone encounters or other forms of communication with the patients or their referring physicians, are documented electronically. Event recorders and device interrogation, whenever available, are also employed for arrhythmia documentation. Patients are instructed to transmit cardiac recordings whenever symptomatic and on a weekly basis even when asymptomatic for 3 months after their procedures. Additional event recorder monitoring is obtained beyond the 3-month period for patients with documented arrhythmia and those who develop symptoms suggestive of arrhythmia during the initial 3-month period. Patients have scheduled clinical visits and 12-lead electrocardiograms at 3, 6, and 12 months after the procedure and every 6 months thereafter, whenever possible. Arrhythmia recurrence is defined per current guidelines as electrocardiographic documentation beyond a 3-month blanking period of an atrial tachyarrhythmia, lasting ≥30 s, on a 12-lead ECG, event recording, or Holter monitor recording.
Study Outcomes and Statistical Analyses
In assessment of the first clinical application of the automated PRO system in a population of patients undergoing AF ablation, we aimed to compare in primary analyses data availability and follow-up duration with automated PRO in addition to routine clinical follow-up versus routine clinical follow-up alone (primary outcome). In terms of follow-up data availability, the variables that counted towards assessments were clinical visits or completed PRO surveys. This was investigated in the overall population (N=2530) regardless of whether or not patients had email accounts, to assess the overall benefit of introducing this tool in a population of patients undergoing AF ablation. In a secondary analysis, we investigated the impact of AF ablation procedures on QoL, AF burden, and healthcare utilization as collected by the automated PRO system (secondary outcomes). This secondary comparison was performed in those patients who participated in PRO surveys. All statistical analyses were performed by using JMP pro version 10.0 (SAS; NC). Continuous variables are presented as mean±SD or median (interquartile range) as appropriate. The χ 2 test was used for comparison of proportions. For continuous variables, the ANOVA or the nonparametric Wilcoxon rank-sum test were used, as appropriate. A 2-sided P value <0.05 was considered statistically significant. The P values for comparisons of outcomes at various time points during follow-up are P values for overall differences of such outcomes at various time points unless otherwise specified.
RESULTS

Implementation of Automated PRO System in AF Ablation
For assessment of the automated PRO system in AF ablation, the study population included all 2530 consecutive patients who underwent AF ablation procedures at the Cleveland Clinic between November 2013 and November 2016 (Figure 1 ). The automated process was triggered by the scheduling software for initiation of baseline and follow-up surveys for every patient being scheduled for an AF ablation procedure.
Patients (N=2530) were 63.6±10.1 years old, and 71.7% of them were males. The ablation procedures were performed for recurrent symptomatic paroxysmal AF in 50.5% of them, whereas the remaining 49.5% underwent ablation for nonparoxysmal AF. Of the procedures, 66.5% were first-time AF ablation procedures, and the remaining were repeat ablation procedures that were performed for recurrent symptomatic arrhythmias after prior AF ablations at other institutions or at our center before implementation of the automated PRO system.
Baseline participation invitations were sent to all 1833 consecutive patients with available email addresses at baseline. The number of eligible patients with email addresses increased to 2175 (86% of all patients undergoing ablation) at 3 months after the procedures. In all, 2175 patients were eligible to receive 10 903 PRO assessment invitations and the automated PRO system sent all 10 903 invitations on time, as programmed. Of those, 5984 online surveys were started (59.4%) by patients, and 5461 were completed (50.1%). In addition, any data from incomplete surveys (n=523) were available for review and analysis. The median delay to complete surveys from invitation time was 1 day (25th-75th percentile 0-3). The median time needed to complete the surveys was 10 minutes (25th-75th percentile 7-16).
Primary Outcome: Follow-Up Data Availability and Duration
Both follow-up data availability and duration were improved by the addition of automated PRO to routine clinical follow-up (Figure 2 
Secondary Outcomes: Disease-Specific Data by Automated PRO
Disease-specific PRO data showed significant improvement in QoL and reduction in AF burden and associated healthcare use after the ablation procedures (Figures 3, 4 , and 5).
The median AF symptom severity score was 12 (6-18) at baseline and ranged between 2 and 3 on subsequent assessments (P<0.0001; Figure 3A ). There was, in fact, a significant improvement in each of the individual components of the AF symptom severity score by PRO including severity of (1) palpitations, (2) dyspnea at rest, (3) dyspnea with exertion, (4) exercise intolerance/ fatigue with mild physical activity, (5) fatigue at rest, (6) lightheadedness/ dizziness, and (7) chest pain/ pressure ( Figure I in the Data Supplement).
Overall, 75.9% of patients reported marked improvement in their overall AF-related symptoms after the ablation procedure, whereas 9.2% reported moderate improvement, 5.5% reported mild improvement, and the remaining 9.4% reported no change or worsening (Figure 3) . The reported improvements in overall AF-related symptoms were true for both short term and long term follow-up after the procedure (Figure 3 ). This translated into improvement in patient-assessed overall QoL, which was sustained during the follow-up duration (Figure 3) .
The proportion of patients in AF at the time of completion of the baseline survey was 35.9%, and this decreased to <5% on short and long term follow-up (P<0.0001; Figure 4 ). There was also a reduction in both AF frequency and duration of episodes (P<0.0001 for both; Figure 4 ).
At baseline, 42.4% of patients reported having made at least 1 visit to the emergency department because of AF within the prior year, and this proportion was consistently <10% on follow-up beyond the first year after ablation (P<0.0001; Figure 5) . Similarly, 49.2% of patients reported being hospitalized at least once because of AF within the prior year, and this proportion was consistently <10% on follow-up beyond the first year after ablation (P<0.0001; Figure 5 ).
In terms of medical management of AF, the proportion of patients on anticoagulants, rhythm, or rate control agents decreased on follow-up, whereas the proportion of patients on antiplatelet agents increased (P<0.0001 for all; Figure 5 ).
AF Ablation Outcomes Based on Electrocardiographic Documentation
The freedom from recurrent atrial arrhythmia off antiarrhythmic drugs at 1-year of follow-up after a single ablation procedure in this population (N=2530) was 75.8% (79.6% in paroxysmal and 71.9% in nonparoxysmal AF). At last follow-up after a single ablation procedure, 66.7% of patients remained arrhythmia free off antiarrhythmic drugs (72.1% in paroxysmal and 61.1% in persistent AF).
In patients who completed the baseline survey (n=1086), the 1-year success rate off antiarrhythmic drugs of a single ablation procedure was 77.5% (81.4% in paroxysmal and 72.4% in nonparoxysmal AF). The ablation success rate off antiarrhythmic drugs at last follow-up of a single ablation procedure was 69.2% (74.1% in paroxysmal and 62.7% in persistent AF). Between enrolment and last follow-up, the AF symptom severity score decreased from baseline by a median of 6 points (25th-75th percentiles 1-11). Overall, there was a decrease in AF symptom severity scale by ≥1 point in 80.7% of patients (84.6% of those without arrhythmia recurrence, 71.8% of those with arrhythmia recurrence). The ablation success rates, based on electrocardiographic documentation, were significantly higher with increasing quartiles of change from baseline of the AF symptom severity score by PRO ( Figure II in the Data Supplement)
DISCUSSION
In this study, a novel fully automated system for collection of patient-reported outcomes complemented routine clinical care by increasing the number of followup assessments and duration of follow-up, compared with routine care alone. Follow-up after AF ablation is uniquely suited for PRO and as implemented in our current report. The automated PRO system was found to reliably send participation surveys to eligible patients in a timely fashion. This automated system allowed collection of patient-reported disease-specific outcomes and showed improvement in QoL, AF burden, and healthcare utilization after the ablation procedures.
Although traditional clinical research and randomized clinical trials have focused on standard metrics, such as survival and pathophysiological outcomes, Institute with a primary goal to assess health outcomes in a patient-centered approach. Indeed, viewing healthcare quality from patients' perspective is gaining momentum in an era of social media, online forums, and online reviews.
Furthermore, PRO are currently viewed as the cornerstone of patient-centered care, but collecting and maintaining longitudinal PRO data may be cost prohibitive especially with reductions in healthcare reimbursement, efforts to further reduce costs of care, and absence of government's strong financial incentives to collect and maintain PRO. Automated PRO systems may provide a practical method to collect such outcomes. The survey completion rate in this study was about 50% which is higher than reported completion rates of Centers for Medicare and Medicaid Services Hospital Consumer Assessment of Healthcare Providers and Systems surveys, which have typically ranged between 27 and 30%. This reflects the challenges related to collecting and maintaining patient-reported data in clinical practice. Nonetheless, PRO are not meant to replace routine clinical follow-up but rather complement it, as highlighted by findings of automated PRO in the current report.
In the specific example of atrial fibrillation, ablation procedures in clinical practice are primarily performed to relieve symptoms and improve QoL. 9 ,10 Yet, the vast majority of AF ablation outcomes studies have reported primarily on arrhythmia recurrence rates, strictly defining recurrences as the occurrence of any arrhythmia lasting ≥30 s, and as such may have underestimated the net benefit to patients. 9,10 A significant reduction of AF burden following an ablation procedure may still be considered a successful outcome in a patient-centered approach when it translates into improvement in overall or disease-related QoL. Furthermore, published data suggest that physicians and patients may differ in their perception of symptoms' relief after ablation procedures. 11 The discrepancy might be related to bias in assessment and reporting, such as the treating physician, may have a bias towards maximizing the ablation's benefit, whereas patients may report more accurately when completing a survey versus being directly questioned. These observations emphasize the importance of PRO.
In addition, PRO enhance discussions with patients in shared decision making and may improve physicians' workflow efficiency. 5 Importantly, for academic tertiary care centers with a national referral base, automated PRO may enhance clinical follow-up and provide insights about disease progression, response to treatment and most importantly introduce opportunities for interventions and research to improve clinical care.
Study Limitations
The findings of this study represent a single center's experience. The benefits of an automated PRO system on a large multicenter scale deserve further investigation. Similarly, the population of patients in this study is from a referral center and may not be representative of community practices, especially in terms of access to technology. In an era of smartphone technology, such limitation may be less of a concern in the near future as technologies continue to evolve and become readily available to most. It is difficult based on available data to assess the socioeconomic status of patients who had email accounts versus those who did not, but these were comparable in terms of age and sex. Also, residual bias or confounding cannot be fully excluded when surveys are not completed by all patients, a known limitation to surveys and current models of quality assessments including surveys by Centers for Medicare and Medicaid Services. Finally, the role of clinical interventions in real time based on PRO data is yet to be determined.
Conclusions
A fully automated system for PRO collection enhanced clinical follow-up and allowed collection of disease-specific data. Applied in patients undergoing AF ablation procedures, the automated system allowed collection of disease-specific outcomes and showed improvement in QoL, AF burden and healthcare utilization after the ablation procedures.
